Abstract : During the past decade, modular multifunctional polyketide synthases (PKSs) have presented an exciting paradigm for the controlled genetic manipulation of complex natural product biosynthesis. These enzymes catalyze the biosynthesis of polyketide natural products by stepwise condensation and modification of metabolically derived building blocks such as malonyl-, methylmalonyl-, ethylmalonyl-, and methoxymalonyl-CoA. Many new tools for genetic manipulating and studying these multifunctional enzymes in vitro have been developed. The most significant recent advances in combinatorial biosynthesis, which is more rational and faster methods of engineering new compounds for the development of biological active agents from natural products, are reviewed.
aglycone of the broad-spectrum antibiotic erythromycin A (Figure 1 ).3,10 The formation of 6-dEB (1) involves six condensation steps beginning with a propionyl-CoA starter unit and six methylmalonyl-CoA extender units. The six modules of DEBS are organized into three bimodular, homodimeric proteins, DEBS1, DEBS2, and DEBS3.11 At the N-terminus of module 1 in DEBS1 is a specialized set of AT and ACP domains that together are responsible for loading of the propionyl-CoA primer unit. The C-terminus of DEBS3 carries a thioesterase (TE) domain that releases the heptaketide product from ACP6 by cyclization to the macrolactone 6-dEB (1).
Combinatorial Biosynthesis Tools for Polyketide Natural Products
Although, homologous recombination is a particularly attractive strategy for manipulating extremely complex PKSs encoded by large gene clusters, the genetic engineering of PKSs in the chromosome of homologous organisms for microbial polyketides is often technically difficult and relatively slow because exogenous recombinant genes must be discriminated. Accordingly, an alternative strategy for combinatorial biosynthesis involves a heterologous cxprcssion system of selected PKS genes in suitable hosts. Additionally, the heterologous expression system offers the advantage of relatively easy access to PKS proteins through over expression similarly to those of wild strain. The production of the 6-dEB analog was made possible by a plasmid-based heterologous expression system developed for Streptomyces coelicolor, a model actinomycetes with a well-developed genetic too1.12 An improvement to this approach was achieved by concomitant expression of modular PKS genes from a multiple plasmid system developed for Streptomyces and was used to generate a library of 6-dEB analogs: 3,14 Up to the past few years, growth in the number of new PKS gene clusters has been rapidly witnessed and sequenced, and several manipulations of these have been adapted to heterologous expression systems, including the gene clusters encoding epothilone7, oleandomycin15, megalomicin16 and picromycin17. Increasingly, the activity in the field of combinato- ( 29 ) rial biosynthesis has also led to more widespread use of genetic tools in various actinomycetes hosts. Several new hosts for manipulation have subsequently been reported, including S. coelicolor,12 Streptomyces lividans18 and Streptomyces venezuelae19 that is the methymycin/picromycin producer. The most impressive advances in PKS expression host have occurred in gram-positive bacterial strain Escherichia coli, which has been used for the overexpression of PKS proteins in a number of in vitro studies.2° Moreover, the final 6-dEB (1) producing E. coli strain engineered by Pfeifer et al. 21 included the sfp phosphopantetheinyl transferase gene2° from an NRPS cluster in Bacillus subtilis, overexpression of the native prpE propionyl-CoA synthase, disruption of the propionyl-CoA catabolic pathway, and the pcc propionylCoA carboxylase genes from S. coelicolor22 to convert propionyl-CoA to (25)-methylmalonyl-CoA. This significant technological achievement in E. coil promises to greatly accelerate the rate at which combinatorial biosynthesis tools can be developed. Indeed, when cultivated at high cell densities similar to that of Streptomyces, this derivative of E. coli BAP1 harboring DEBS1, 2 and 3 could accomplish titers of 6-dEB (1) up to 200 mg/L.21 As those mentioned above, the use of biosynthetic genes from heterologous hosts suggests that other important polyketide precursors produced by fungus may also be expressed in E. coli.
Biochemical Analysis of Modular Polyketide Synthases in vitro
The situation of detailed mechanistic studies on microbial PKSs has changed dramatically over the past decade with several reports demonstrating enzymatic synthesis of polyketides using the PKS responsible for the polyketide component of the tetracenomycin synthase23, the truncated forms of modular PKSs in DEBS and the completed the DEBS assembly.24 '25 In the case of PKSs, some well-established questions about polyketide biosynthesis are as follows. How are their molecular recognition features cognizable among different subunits, domains, and modules? How tolerant is the interrelationship between the intrinsic substrate specificity of individual enzymes and the structures of their natural substrates? How strong is the discrimination of individual enzymes toward unnatural substrates?
The full DEBS proteins were achieved in a cell-free protein preparation from S. coelicolor CH999/pCK7. 26 In the presence of propionyl-CoA, (216)-methylmalonyl-CoA, and NADPH in a sodium phosphate buffer, the multifunctional enzyme assembly was found to catalyse the formation of 6-dEB (1) (Figure 2a ).22 Analogous to the above studies with the complete DEBS system, more comprehensive investigations have also been carried out on the formation of the triketide lactone 2 by the truncated DEBS 1 TE protein preparation from S. coelicolor CH999/pCK9. Substitution of acetyl-CoA or butyryl-CoA for propionyl-CoA resulted in formation of the corresponding C 8-and C 10-triketide lactone analogues 3 and 4 (Figure 2b ).27 ' 28 In competition experiments, DEBS 1 TE showed a 32-fold preference in kcat/Km for propionyl-CoA over acetyl-CoA.26 '29 This kinetic preference, which must reflect individual rate constants up to and including the first irreversible enzymatic step, is most likely caused by the intrinsic rate of acylation of the active site serine of the AT loading domain. The use of full and partial modular polyketide synthases in specific reactions in combination with surrogate substrates has provided a powerful tool to produce novel analogues of medicinally important natural products by the engineered biosynthesis. Moreover, a major demand on the successful accomplishment of this promising tool is a better understanding of the structural and stereochemical features that influence the processing of substrate analogues by individual polyketide synthase modules. The individual DEBS modules 2, 3, 5, and 6 with the C-terminus of natural DEBS thioesterase (TE) domain have been expressed and purified from Escherichia coli.3° Incubation of (25, 3R)-2-methyl-3-hydroxypentanoyl-SNAC diketide 5 with modules 2, 5, or 6 + TE in the presence of methylmalonyl-CoA and NADPH resulted in formation of the triketide lactone 2 (Figure 2c ), whereas incubation of 5 with module 3 + TE gave rise to the 3-keto-triketide lactone for the inactivated KR3 (Figure 2d ). The intrinsic substrate specificity on each of these recombinant modules has been also compared by the natural (2S, 3R)-2-methyl-3-hydrox- Furthermore, the anhydro-triketide thioester (12), an intermediate in the formation of tylactone, was also processed by the KS2 domain of DEBS (KS1°), resulting in the formation of the 16-membered lactone (13),32 whereas the epimeric triketide thioester (14) , with the natural erythromycin stereochemistry at C-4, was apparently recognized as a triketide by KS3 and converted to the 10,11-anydro analogue of 6-dEB (15) (Figure 5 ).33C As mentioned above, the balance between intrinsic substrate specificity and tolerance for structural variations by individual KS domains holds the key to the exploitation of modular polyketide synthases for combinatorial biosynthesis. Such precursor-directed biosynthesis has provided a powerful tool to generate a wide range of novel polyketides by exploiting the apparently broad substrate specificity of DEBS KS2. Exogenous addition of diketide mimics to small-scale cultures of this null mutant resulted in highly selective multi-milligram production of unnatural polyketides.28 In particular, the unexpected incorporation of the presumed triketide intermediate as a diketide, and the cyclization of its fully elongated product into a 16-membered macrolactone, underscores the flexibility of the DEBS modules. The catalytic potential of this pathway could be harnessed by feeding to the organism a cell-permeable synthetic molecule that is suitably designed so as to be selectively loaded onto any desired PKS module at the corresponding KS domain.33e Moreover, by utilizing surrogate diketide and triketide analogues, it is possible to exploit the apparently broad substrate specificity of the DEBS KS2 domain to generate a wide range of 6-dEB derivatives.33 More recently, the versatility of this precursor-directed biosynthesis technology has been developed in the E. coli BAP1 harboring a DEBS mutant from which the entire loading didomain and DEBS module 1 have been deleted. The unsaturated triketide thioesters 12 and 14, however, were not incorporated and converted to the expected macrolactone products 13 and 15 by the engineered E. coli strain, possibly reflecting uptake and /or metabolic differences between E. coli and S. coelicolor.33g
Genetic Manipulation of Modular Polyketide Biosynthesis
The availability of the cloned DEBS structural genes opened the door to genetic modification of the DEBS proteins themselves. As shown in Figure 6 , the pioneering demonstration by Katz et al. that KS domains might be able to accept modifications in their natural substrates evolved from the finding that mutagenic inactivation of the KR5 or ER4 domains of DEBS led to the formation of the corresponding 5-keto-6dEB (16)34 and 6,7-anhydro-6dEB (17)35 derivatives, respectively. These results indicated that the KS6 domain and all other domains in module 6 as well as the TE could accept the unreduced /3-ketoacyl precursor of its natural /3-hydroxyacyl hexaketide substrate, whereas the KS5 and KS6 domains would tolerate the corresponding enoylacyl-ACP analogue of the natural reduced pentaketide intermediate. A further impressive demonstration by KOSAN's researchers is that a combinatorial library of 6-dEB analogs was produced by engineering simultaneous changes in multiple modules of DEBS.36 The corresponding novel macrolides were produced with up to three modifications at one or more carbon centers, demonstrating that multiple changes in a polyketide pathway could be carried out. The 6-deoxyerythronolide B synthase (DEBS) from Saccharopolyspora erythraea37' 38 and the heterologous host of S. lividans36 have been the most widely used system to create enzymes that synthesize new molecules and have served as a model system for discovering ways to engineer PKSs and exploring the structural plasticity and substrate tolerance of modular PKSs. 
